Atom Investors LP Invests $1.70 Million in Genpact Limited (NYSE:G)

Atom Investors LP bought a new stake in Genpact Limited (NYSE:G - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 43,221 shares of the business services provider's stock, valued at approximately $1,695,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. CWM LLC increased its position in shares of Genpact by 160.8% in the 2nd quarter. CWM LLC now owns 952 shares of the business services provider's stock valued at $31,000 after acquiring an additional 587 shares during the period. Massmutual Trust Co. FSB ADV lifted its holdings in shares of Genpact by 54.3% during the second quarter. Massmutual Trust Co. FSB ADV now owns 2,797 shares of the business services provider's stock worth $90,000 after purchasing an additional 984 shares during the period. Venturi Wealth Management LLC boosted its position in Genpact by 74.6% in the third quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider's stock valued at $103,000 after buying an additional 1,121 shares during the last quarter. GAMMA Investing LLC increased its holdings in Genpact by 221.3% in the 3rd quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider's stock worth $131,000 after buying an additional 2,293 shares during the period. Finally, Centaurus Financial Inc. purchased a new position in Genpact during the 3rd quarter worth approximately $159,000. 96.03% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Balkrishan Kalra sold 9,000 shares of the stock in a transaction on Monday, November 25th. The stock was sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares of the company's stock, valued at $12,407,545.60. This trade represents a 3.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 2.80% of the company's stock.

Genpact Trading Down 0.5 %

Shares of NYSE G traded down $0.24 during trading on Tuesday, reaching $46.05. The stock had a trading volume of 440,872 shares, compared to its average volume of 1,340,984. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85. The company has a market cap of $8.12 billion, a P/E ratio of 12.71, a PEG ratio of 1.59 and a beta of 1.17. The business's 50-day moving average price is $41.31 and its 200-day moving average price is $37.10. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $47.98.

Genpact Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 9th will be given a dividend of $0.1525 per share. This represents a $0.61 annualized dividend and a dividend yield of 1.32%. The ex-dividend date of this dividend is Monday, December 9th. Genpact's dividend payout ratio (DPR) is presently 16.76%.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. JPMorgan Chase & Co. raised their price objective on shares of Genpact from $35.00 to $43.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Jefferies Financial Group upped their price objective on shares of Genpact from $35.00 to $40.00 and gave the stock a "hold" rating in a research report on Monday, September 9th. BMO Capital Markets lifted their price target on Genpact from $38.00 to $42.00 and gave the company a "market perform" rating in a research note on Monday, August 12th. Needham & Company LLC increased their price target on Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a research report on Monday, November 11th. Finally, Robert W. Baird boosted their price objective on Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Eight research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, Genpact currently has an average rating of "Hold" and an average target price of $42.33.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.